Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2084881000168116 | sebelipase alfa 20 mg / 10 mL injection, 10 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2084891000168118 | sebelipase alfa 20 mg/10 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sebelipase alfa 20 mg/10 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| sebelipase alfa 20 mg/10 mL injection, vial | Is a | sebelipase alfa | true | Inferred relationship | Some | ||
| sebelipase alfa 20 mg/10 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| sebelipase alfa 20 mg/10 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 252794861 | |
| sebelipase alfa 20 mg/10 mL injection, vial | has Australian BoSS | sebelipase alfa | true | Inferred relationship | Some | 252794860 | |
| sebelipase alfa 20 mg/10 mL injection, vial | has intended active ingredient | sebelipase alfa | true | Inferred relationship | Some | 252794860 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| sebelipase alfa 20 mg/10 mL injection, 10 mL vial | has MPUU | True | sebelipase alfa 20 mg/10 mL injection, vial | Inferred relationship | Some | 1 |
| Kanuma 20 mg/10 mL injection, 10 mL vial | Is a | True | sebelipase alfa 20 mg/10 mL injection, vial | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR